At the same time, our data show that DHCR24 induces CYP27A1 expression and increases HMGCR and CYP27A1 expression in vemurafenib-resistant melanoma cell lines, suggesting an enhanced regulatory loop mechanism. Here, DHCR24 is linked to melanoma.